您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Clenbuterol(hydrochloride)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Clenbuterol(hydrochloride)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Clenbuterol(hydrochloride)图片
CAS NO:21898-19-1
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)电议
25mg电议
50mg电议
100mg电议

产品介绍
sympathomimetic β2-adrenoceptor agonist used as a bronchodilator in the treatment of pulmonary diseases
Cas No.21898-19-1
别名盐酸克仑特罗,NAB 365,Ventipulmin
化学名4-amino-3,5-dichloro-α-[[(1,1-dimethylethyl)amino]methyl]-benzenemethanol, monohydrochloride
Canonical SMILESClC1=CC(C(O)CNC(C)(C)C)=CC(Cl)=C1N.Cl
分子式C12H18Cl2N2O o HCl
分子量313.7
溶解度≥ 13.15mg/mL in DMSO
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Clenbuterol is a sympathomimetic β2-adrenoceptor agonist.

β2-adrenoceptor agonists, mainly long-acting β2-adrenoceptor agonists, are an important pharmacological approach to induce bronchodilation in patients with chronic obstructive pulmonary disease.

In vitro: A hormone dependent human breast cancer cell line was treated with different concentrations of clenbuterol. It was found that clenbuterol could stimulate cell proliferation at low concentrations, but the effect was less marked and significant compared with oestradiol. Probably clenbuterol elicited cell proliferation via a different mechanism, because it did not affect the cellular oestrogen receptor concentration [1].

In vivo: Clenbuterol was administered to Fischer-344 rats, at a dose of 1.5 mg/kg/24 h for 3 weeks. The weights of five hindlimb muscles and carcass protein and fat content were determined. Results showed that clenbuterol treatment could increase the weight of skeletal muscles of all animals. Similarly, clenbuterol increased carcass protein conten, leading to the reduced carcass fat content [2].

Clinical trial: Clenbuterol was compared with terbutaline during a 5-week single-blind crossover study in patients with chronic airways obstruction. Both clenbuterol and terbutaline could significantly improve baseline FEV1 and the bronchodilator effects were similar, suggesting that clenbuterol was a good alternative drug for treatment of chronic airways obstruction [3].

References:
[1] Re G, Badino P, Girardi C, Di Carlo F.  Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells. Pharmacol Res. 1992 Dec;26(4):377-84.
[2] Carter WJ, Dang AQ, Faas FH, Lynch ME.  Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats. Metabolism. 1991 Aug;40(8):855-60.
[3] Brusasco V, Crimi E, Mangini S, Vibelli C.  A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction. Curr Med Res Opin. 1980;6(7):449-55.